EAST BRUNSWICK, N.J., Nov. 7, 2011 /PRNewswire/ -- Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) and Jim Belushi today announced the launch of a new educational campaign, "Check Out Your Gout," to raise awareness about gout and a severe form of the condition known as refractory chronic gout, or RCG. As an actor, singer and performer, Belushi's roles range from dramatic to light-hearted, but when it comes to his gout – he is nothing but serious. The "Check Out Your Gout" campaign aims to encourage people to get serious about gout and take action to learn more about the condition. Launched from Chicago, Belushi's hometown and location of the 2011 Annual Meeting of the American College of Rheumatology taking place this week, the campaign will feature broadcast and online videos, as well as an educational website, CheckOutYourGout.com.
To view the multimedia content associated with this release, please click: http://www.multivu.com/players/English/51932-savient-pharmaceuticals-and-jim-belushi-launch-gout-awareness-campaign/
Gout is a debilitating form of arthritis affecting approximately eight million Americans. Triggered by high levels of uric acid in the blood, gout causes pain and swelling in the joints and can result in deposits of uric acid crystals under the skin, called tophi. RCG occurs when uric acid levels remain high, and signs and symptoms persist despite available conventional therapies. RCG signs and symptoms may be debilitating due to the frequency and severity of episodes, the recurrent painful gout attacks and the disfigurement associated with the condition."When I first developed gout, I didn't want to do anything about it. I thought I could tough it out; but when the pain became too unbearable for me to perform on stage, I saw a rheumatologist and got my gout under control," said Belushi. "I am taking part in the 'Check Out Your Gout' campaign to let people know that gout is a very painful condition that should be taken seriously, and to tell those who are or may be affected by gout or RCG to check it out and work with a doctor to identify the best management plan."
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV